Luke A Masterson (Luke Masterson)

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 3

Top Topics

Diffusion Weighted Imaging

Emergency Department

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Krista Kinneer, Philipp Wortmann, Zachary A Cooper, Niall J Dickinson, Luke A Masterson, Thais Cailleau, Ian Hutchinson, Balakumar Vijayakrishnan, Mary McFarlane, Kathryn Ball, Michael Davies, Arthur Lewis, Yue Huang, Anton I Rosenbaum, Jiaqi Yuan, Jon Chesebrough, Judith Anderton, Noel Monks, Steven J Novick, Jixin Wang, Nazzareno Dimasi, R James Christie, Darrin Sabol, Frances Anne Tosto, Yann Wallez, Elisabetta Leo, Mark R Albertella, Anna D Staniszewska, David A Tice, Philip W Howard, Nadia Luheshi, Puja Sapra
Design and Preclinical Evaluation of a Novel B7-H4-Directed Antibody-Drug Conjugate, AZD8205, Alone and in Combination with the PARP1-Selective Inhibitor AZD5305. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Stephen J Gregson, Kathryn M Pugh, Neki Patel, Shameen Afif-Rider, Balakumar Vijayakrishnan, Kathleen Santos, Jitka Riedl, Ian Hutchinson, Gyoung-Dong Kang, K Phin Chooi, Rhiannon Beard, Lauren Adams, Conor S Barry, Kathryn Ball, Luke A Masterson, Mary McFarlane, John A Hartley, Philip W Howard
Efficacy, Tolerability, and Pharmacokinetic Studies of Antibody-Drug Conjugates Containing a Low-Potency Pyrrolobenzodiazepine Dimer. Molecular cancer therapeutics 21 (9) (2022)
Jason B White, Ryan Fleming, Luke A Masterson, Ben T Ruddle, Haihong Zhong, Christine Fazenbaker, Patrick Strout, Kim Rosenthal, Molly Reed, Vanessa Muniz-Medina, Philip Howard, Rakesh Dixit, Herren Wu, Mary Jane Hinrichs, Changshou Gao, Nazzareno Dimasi
Design and characterization of homogenous antibody-drug conjugates with a drug-to-antibody ratio of one prepared using an engineered antibody and a dual-maleimide pyrrolobenzodiazepine dimer. mAbs 11 (3) (2019)